You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/67779
Full metadata record
DC FieldValueLanguage
dc.contributor.authorViegas Jr., Cláudio-
dc.contributor.authorBolzani, Vanderlan da Silva-
dc.contributor.authorFurlan, Maysa-
dc.contributor.authorManssour Fraga, Carlos Alberto-
dc.contributor.authorBarreiro, Eliezer J.-
dc.date.accessioned2014-05-27T11:21:06Z-
dc.date.accessioned2016-10-25T18:19:41Z-
dc.date.available2014-05-27T11:21:06Z-
dc.date.available2016-10-25T18:19:41Z-
dc.date.issued2004-07-01-
dc.identifierhttp://dx.doi.org/10.1590/S0100-40422004000400021-
dc.identifier.citationQuimica Nova, v. 27, n. 4, p. 655-660, 2004.-
dc.identifier.issn0100-4042-
dc.identifier.urihttp://hdl.handle.net/11449/67779-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/67779-
dc.description.abstractAlzheimer's disease (AD) is a progressive neurodegenerative pathology with severe economic and social impact. There is currently no cure, although cholinesterase inhibitors provide effective temporary relief of symptoms in some patients. Nowadays drug research and development are based on the cholinergic hypothesis that supports the cognition improvement by regulation of the synthesis and release of acetylcholine in the brain. There are only four commercial medicines approved for treatment of AD and natural products have played an important role in the research for new acetylcholinesterase inhibitors.en
dc.format.extent655-660-
dc.language.isopor-
dc.sourceScopus-
dc.subjectAcetylcholinesterase-
dc.subjectAlzheimer's disease-
dc.subjectNatural products-
dc.subject11 hydroxygalantamine-
dc.subject9 o norgalantamine-
dc.subjectacetylcholine-
dc.subjectcholinesterase inhibitor-
dc.subjectdonepezil-
dc.subjectgalantamine-
dc.subjectGinkgo biloba extract-
dc.subjectnatural product-
dc.subjectrivastigmine-
dc.subjecttacrine-
dc.subjectunclassified drug-
dc.subjectacetylcholine release-
dc.subjectAlzheimer disease-
dc.subjectbrain function-
dc.subjectcholinergic activity-
dc.subjectcognition-
dc.subjectconference paper-
dc.subjectdegenerative disease-
dc.subjectdrug efficacy-
dc.subjectdrug indication-
dc.subjectdrug synthesis-
dc.subjecteconomic aspect-
dc.subjecthypothesis-
dc.subjectneuropathology-
dc.subjectregulatory mechanism-
dc.subjectsocial aspect-
dc.titleProdutos naturais como candidatos a fármacos úteis no tratamento do mal de Alzheimerpt
dc.title.alternativeNatural products as candidates for useful drugs in the treatment of Alzheimer's diseaseen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversidade Federal do Rio de Janeiro (UFRJ)-
dc.description.affiliationInstituto de Química Univ. Estadual Paulista Julio M., CP 355, 14801-970 Araraquara - SP-
dc.description.affiliationFaculdade de Farmácia Univ. Federal do Rio de Janeiro, CP 68006, 21941-590 Rio de Janeiro - RJ-
dc.identifier.doi10.1590/S0100-40422004000400021-
dc.identifier.scieloS0100-40422004000400021-
dc.identifier.wosWOS:000223108900021-
dc.rights.accessRightsAcesso aberto-
dc.identifier.file2-s2.0-15044356788.pdf-
dc.relation.ispartofQuímica Nova-
dc.identifier.scopus2-s2.0-15044356788-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.